Q32 Bio Inc. (QTTB)

USD 3.13

(-8.75%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 1.15 Million 6.65 Million 33.97 Million 2.7 Million 1.66 Million 5.32 Million
Cost of Revenue 578 Thousand 2.59 Million 9.54 Million - - -
Gross Profit 578 Thousand 4.05 Million 24.42 Million 2.7 Million 1.66 Million 5.32 Million
Operating Expenses 92.68 Million 45.87 Million 36.69 Million 124.06 Million 105.29 Million 63.95 Million
Selling, General and Administrative Expenses 30.67 Million 10.06 Million 6.76 Million 23.66 Million 15.89 Million 16.01 Million
Research and Development Expenses 62 Million 35.81 Million 29.92 Million 100.39 Million 89.39 Million 47.94 Million
Other Expenses - -1.12 Million -324 Thousand - - -
Cost and Expenses 93.25 Million 45.87 Million 36.69 Million 132.96 Million 111.6 Million 65.24 Million
Operating Income -92.1 Million -39.22 Million -36.69 Million -130.26 Million -109.94 Million -59.92 Million
Interest Expense - - - - - -
Income Tax Expense 25.88 Million 62 Thousand 547 Thousand -1.00 - -
Earnings before Tax -87.08 Million -42.74 Million -37.01 Million -128.69 Million -103.91 Million -55.57 Million
Net Income -112.96 Million -42.8 Million -37.56 Million -128.69 Million -103.91 Million -55.57 Million
Earnings Per Share Basic -35.16 -13.42 -12.23 -50.46 -44.41 -35.04
Earnings Per Share Diluted -35.16 -13.42 -12.23 -50.46 -44.41 -35.04
Weighted Average Shares Outstanding 3.21 Million 3.18 Million 3.07 Million 2.55 Million 2.33 Million 1.58 Million
Weighted Average Shares Outstanding (Diluted) 3.21 Million 3.18 Million 3.07 Million 2.55 Million 2.33 Million 1.58 Million
Gross Margin 0.50 0.61 0.72 1.00 1.00 1.00
EBIT Margin -74.83 -5.48 -1.08 -44.91 -62.20 -11.02
Profit Margin -97.72 -6.44 -1.11 -47.63 -62.37 -10.44
EBITDA -86.5 Million -38.85 Million -86.22 Million -121.35 Million -103.62 Million -58.63 Million
Earnings Before Tax Margin -79.67 -5.90 -1.08 -48.21 -65.99 -11.26

Income Statement Charts